Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

Available items only

Corporate Author

Title Generic drug entry prior to patent expiration : an FTC study / Federal Trade Commission.

Imprint

[Washington, D.C.] : Federal Trade Commission, [2002]

Connect to
Connect to https://permanent.fdlp.gov/websites/www.ftc.gov/os/2002/07/genericdrugstudy.pdf

Location	Call No.	OPAC Message	Status
Axe Federal Documents Online	FT 1.2:2002023216	---	Available

Description	1 online resource
	text txt rdacontent
	computer c rdamedia
	online resource cr rdacarrier
Note	Title from PDF title page (viewed Sept. 20, 2005).
	"July 2002."
Summary	In April 2001, the Commission began an industry-wide study focused on certain aspects of generic drug competition under the Hatch-Waxman Amendments. The Amendments provide certain methods by which generic drug manufacturers can obtain approval to market a generic version of a brand-name product. The study's purpose was to provide a more complete picture of how generic drug competition has developed under one method the Amendments established: generic entry prior to expiration of the brand-name company's patents on the relevant drug product.
Subject	Generic drugs -- United States.
	Drugs -- United States -- Patents.
	Drugs, Generic -- economics.
	Legislation, Pharmacy.
	Patents as Topic -- legislation & jurisprudence.
	United States.
	Drugs. (OCoLC)fst00898761
	Generic drugs. (OCoLC)fst00939969
	United States. (OCoLC)fst01204155
Genre/Form	Patents. (OCoLC)fst01423842
Standard No.	NLM 101257205
Gpo Item No.	0535 (online)
Sudoc No.	FT 1.2:2002023216